VivoSim Labs, Inc. Restricted Cash and Cash Equivalents
VivoSim Labs, Inc. (VIVS) had Restricted Cash and Cash Equivalents of $100.00 thousand as of 2019-12-31, per its 10-Q filed 2020-02-10.
Discontinued › Balance Sheet › Assets › Restricted Cash and Investments
us-gaap:RestrictedCashAndCashEquivalents · last filed 2020-02-10
- 2019-12-31: Restricted Cash and Cash Equivalents $100.00K.
- 2019-09-30: Restricted Cash and Cash Equivalents $100.00K.
- 2019-06-30: Restricted Cash and Cash Equivalents $100.00K.
- 2013-03-31: Restricted Cash and Cash Equivalents $50.00K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2019-12-31 | $100.00K 10-Q · filed 2020-02-10 |
| 2019-09-30 | $100.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $100.00K 10-Q · filed 2019-08-08 |
| 2013-03-31 | $50.00K 10-K · filed 2014-06-10 |
| 2012-12-31 | $50.00K 10-K · filed 2014-06-10 |
| 2012-09-30 | $50.00K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $50.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |